Skip to main content
. 2021 May 7;22(4):333–338. doi: 10.5152//TurkThoracJ.2021.20194

Table 1.

Clinical, Demographic, and Anthropometric Features

Parameter n = 43
Age (years) (mean ± SD) 50 ± 15
Male n (%) 15 (34.8)
Female n (%) 28 (65.2)
Age of onset (years) (mean ± SD) 21 ± 20
Duration of disease (years) (mean ± SD) 31 ± 19
BMI (kg/m2) (mean ± SD) 26.2 ± 5.6
Essential symptoms n (%) 37 (86.0)
 Snoring 30 (69.8)
 Excessive daytime sleepiness 32 (74.4)
 Witnessed apnea 11 (25.6)
Sputum colonization n (%) 16 (37.2)
Pseudomonas aeruginosa 10 (23.0)
Candida albicans 1 (2.0)
Escherichia coli 1 (2.0)
Haemophlius influenzae 2 (5.0)
Pseudomonas alcaligenes 1 (2.0)
Klebsiella 1 (2.0)
Brochiectasis localization n (%)
 Right upper lobe 17 (39.0)
 Right middle lobe 19 (44.0)
 Right lower lobe 24 (56.0)
 Left upper lobe 12 (27.0)
 Lingula 20 (46.0)
 Left lower lobe 27 (62.0)
Type of bronchiectasis n (%)
 Cystic 12 (28.0)
 Cylindrical 17 (40.0)
 Varicose 7 (16.0)
 Traction 5 (12.0)
Number of lobes with bronchiectasis n (mean ± SD) 2.3 ± 1.6
Spirometry
 FVC (%) (mean ± SD) 78.9 ± 20.0
 FEV1 (%) (mean ± SD) 64.5 ± 24.1
 FEV1/FVC (%) (mean ± SD) 66.7 ± 13.9
FEV1/FVC<%75 n (%) 29 (67.4)

BMI, body mass index; FEV1, forced expiratory volume in 1 second; FVC, forced vital capacity; SD, standard deviation.